Alterome Therapeutics Funding: $231M Raised, Series A (2022)
Alterome Therapeutics is a Biotech company based in San Diego. It has raised $231M in total funding. Latest round: Series A.
Alterome Therapeutics funding overview
Alterome Therapeutics is a Biotech company based in San Diego. Alterome Therapeutics has raised $231M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for Alterome Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Goldman Sachs Alternatives, OrbiMed, Canaan Partners, Nextech Invest, Vida Ventures, Boxer Capital and 7 others. 13 distinct backers are named across the disclosed rounds.
Frequently asked about Alterome Therapeutics funding
How much has Alterome Therapeutics raised?
Alterome Therapeutics has raised $231M in total disclosed funding across the rounds on record.
Who has invested in Alterome Therapeutics?
Goldman Sachs Alternatives, OrbiMed, Canaan Partners, Nextech Invest, Vida Ventures, Boxer Capital are named among the investors backing Alterome Therapeutics.
What was the latest Alterome Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2022.
Where is Alterome Therapeutics based?
Alterome Therapeutics is based in San Diego.
What sector does Alterome Therapeutics operate in?
Alterome Therapeutics is tracked under Biotech from San Diego, with $231M in disclosed funding.
When did Alterome Therapeutics last raise?
The last disclosed Alterome Therapeutics round closed in January 2022 at Series A.
Every Alterome Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Diego at a similar stage.
